Article Details
Retrieved on: 2024-12-05 23:55:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AbstractBackground. Nirsevimab is an extended half-life, highly potent neutralizing monoclonal antibody against the respiratory syncytial virus ...
Article found on: academic.oup.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here